182 related articles for article (PubMed ID: 37888218)
1. The Influence of Oral Terbinafine on Gut Fungal Microbiome Composition and Microbial Translocation in People Living with HIV Treated for Onychomycosis.
Ouyang J; Yan J; Zhou X; Isnard S; Tang S; Costiniuk CT; Chen Y; Routy JP; Chen Y
J Fungi (Basel); 2023 Sep; 9(10):. PubMed ID: 37888218
[TBL] [Abstract][Full Text] [Related]
2. Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy.
Annavajhala MK; Khan SD; Sullivan SB; Shah J; Pass L; Kister K; Kunen H; Chiang V; Monnot GC; Ricupero CL; Mazur RA; Gordon P; de Jong A; Wadhwa S; Yin MT; Demmer RT; Uhlemann AC
mSphere; 2020 Feb; 5(1):. PubMed ID: 32024712
[TBL] [Abstract][Full Text] [Related]
3. Daily variations of gut microbial translocation markers in ART-treated HIV-infected people.
Ouyang J; Isnard S; Lin J; Fombuena B; Chatterjee D; Wiche Salinas TR; Planas D; Cattin A; Fert A; Moreira Gabriel E; Raymond Marchand L; Zhang Y; Finkelman M; Chen Y; Kaufmann DE; Cermakian N; Ancuta P; Routy JP
AIDS Res Ther; 2020 May; 17(1):15. PubMed ID: 32398104
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of antiretroviral treatment on immunity and gut microbiome composition in people living with HIV in rural versus urban Zimbabwe.
Burkhart Colorado AS; Lazzaro A; Neff CP; Nusbacher N; Boyd K; Fiorillo S; Martin C; Siebert JC; Campbell TB; Borok M; Palmer BE; Lozupone C
Microbiome; 2024 Feb; 12(1):18. PubMed ID: 38310301
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral treatment is less effective at reducing gut microbiome-associated inflammation and T cell activation in people living with HIV in rural versus urban Zimbabwe.
Lazzaro A; Colorado ASB; Neff CP; Nusbacher N; Boyd K; Fiorillo S; Martin C; Siebert J; Campbell T; Borok M; Palmer B; Lozupone C
Res Sq; 2023 Aug; ():. PubMed ID: 37693491
[TBL] [Abstract][Full Text] [Related]
6. Systems Analysis of Gut Microbiome Influence on Metabolic Disease in HIV-Positive and High-Risk Populations.
Armstrong AJS; Quinn K; Fouquier J; Li SX; Schneider JM; Nusbacher NM; Doenges KA; Fiorillo S; Marden TJ; Higgins J; Reisdorph N; Campbell TB; Palmer BE; Lozupone CA
mSystems; 2021 May; 6(3):. PubMed ID: 34006628
[TBL] [Abstract][Full Text] [Related]
7. Oral antifungal medication for toenail onychomycosis.
Kreijkamp-Kaspers S; Hawke K; Guo L; Kerin G; Bell-Syer SE; Magin P; Bell-Syer SV; van Driel ML
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010031. PubMed ID: 28707751
[TBL] [Abstract][Full Text] [Related]
8. The Gut Microbiome, Microbial Metabolites, and Cardiovascular Disease in People Living with HIV.
Peters BA; Burk RD; Kaplan RC; Qi Q
Curr HIV/AIDS Rep; 2023 Apr; 20(2):86-99. PubMed ID: 36708497
[TBL] [Abstract][Full Text] [Related]
9. Cocaine use associated gut permeability and microbial translocation in people living with HIV in the Miami Adult Study on HIV (MASH) cohort.
Hernandez J; Tamargo JA; Sales Martinez S; Martin HR; Campa A; Sékaly RP; Bordi R; Sherman KE; Rouster SD; Meeds HL; Khalsa JH; Mandler RN; Lai S; Baum MK
PLoS One; 2022; 17(10):e0275675. PubMed ID: 36215260
[TBL] [Abstract][Full Text] [Related]
10. The crosstalk between gut barrier impairment, mitochondrial dysfunction, and microbiota alterations in people living with HIV.
Santinelli L; Rossi G; Gioacchini G; Verin R; Maddaloni L; Cavallari EN; Lombardi F; Piccirilli A; Fiorucci S; Carino A; Marchianò S; Lofaro CM; Caiazzo S; Ciccozzi M; Scagnolari C; Mastroianni CM; Ceccarelli G; d'Ettorre G
J Med Virol; 2023 Jan; 95(1):e28402. PubMed ID: 36515414
[TBL] [Abstract][Full Text] [Related]
11. Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.
Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M
Front Immunol; 2021; 12():688886. PubMed ID: 34135912
[TBL] [Abstract][Full Text] [Related]
12. Fungal Translocation Is Associated with Immune Activation and Systemic Inflammation in Treated HIV.
Weiner LD; Retuerto M; Hager CL; El Kamari V; Shan L; Sattar A; Kulkarni M; Funderburg N; Ghannoum MA; Dirajlal-Fargo S; McComsey GA
AIDS Res Hum Retroviruses; 2019 May; 35(5):461-472. PubMed ID: 30784316
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
Gupta AK; Gregurek-Novak T
Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
[TBL] [Abstract][Full Text] [Related]
14. Use of terbinafine in HIV-positive subjects: pilot studies in onychomycosis and oral candidiasis.
Nandwani R; Parnell A; Youle M; Lacey CJ; Evans EG; Midgley J; Cartledge J; Hawkins DA
Br J Dermatol; 1996 Jun; 134 Suppl 46():22-4: discussion 39. PubMed ID: 8763464
[TBL] [Abstract][Full Text] [Related]
15. Terbinafine: a review of its use in onychomycosis in adults.
Darkes MJ; Scott LJ; Goa KL
Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372
[TBL] [Abstract][Full Text] [Related]
16. Translocation of bacterial LPS is associated with self-reported cognitive abilities in men living with HIV receiving antiretroviral therapy.
Isnard S; Royston L; Scott SC; Mabanga T; Lin J; Fombuena B; Bu S; Berini CA; Goldberg MS; Finkelman M; Brouillette MJ; Fellows LK; Mayo NE; Routy JP
AIDS Res Ther; 2023 May; 20(1):30. PubMed ID: 37202809
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and Correlations of the Oral and Gut Fungal Microbiome with Hypertension.
Chen BY; Lin WZ; Li YL; Bi C; Du LJ; Liu Y; Zhou LJ; Liu T; Xu S; Shi CJ; Zhu H; Wang YL; Sun JY; Liu Y; Zhang WC; Zhang Z; Zhang HL; Zhu YQ; Duan SZ
Microbiol Spectr; 2023 Feb; 11(1):e0195622. PubMed ID: 36475759
[TBL] [Abstract][Full Text] [Related]
18. Independent Effects of HIV and Antiretroviral Therapy on the Oral Microbiome Identified by Multivariate Analyses.
Beall CJ; Lilly EA; Granada C; Treas K; Dubois KR; Hashmi SB; Vazquez JA; Hagensee ME; Griffen AL; Leys EJ; Fidel PL
mBio; 2023 Jun; 14(3):e0040923. PubMed ID: 37071004
[TBL] [Abstract][Full Text] [Related]
19. Microbiota-Meditated Immunity Abnormalities Facilitate Hepatitis B Virus Co-Infection in People Living With HIV: A Review.
Ouyang J; Zaongo SD; Zhang X; Qi M; Hu A; Wu H; Chen Y
Front Immunol; 2021; 12():755890. PubMed ID: 35069530
[TBL] [Abstract][Full Text] [Related]
20. Upregulated IL-32 Expression And Reduced Gut Short Chain Fatty Acid Caproic Acid in People Living With HIV With Subclinical Atherosclerosis.
El-Far M; Durand M; Turcotte I; Larouche-Anctil E; Sylla M; Zaidan S; Chartrand-Lefebvre C; Bunet R; Ramani H; Sadouni M; Boldeanu I; Chamberland A; Lesage S; Baril JG; Trottier B; Thomas R; Gonzalez E; Filali-Mouhim A; Goulet JP; Martinson JA; Kassaye S; Karim R; Kizer JR; French AL; Gange SJ; Ancuta P; Routy JP; Hanna DB; Kaplan RC; Chomont N; Landay AL; Tremblay CL
Front Immunol; 2021; 12():664371. PubMed ID: 33936102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
